KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AbCellera Biologics (ABCL) Interest & Investment Income (2022 - 2026)

AbCellera Biologics filings provide 5 years of Interest & Investment Income readings, the most recent being $3.6 million for Q1 2026.

  • Quarterly Interest & Investment Income fell 34.04% to $3.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $23.9 million through Mar 2026, down 28.8% year-over-year, with the annual reading at $28.3 million for FY2025, 26.37% down from the prior year.
  • Interest & Investment Income hit $3.6 million in Q1 2026 for AbCellera Biologics, down from $5.9 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $11.0 million in Q4 2023 and bottomed at $665000.0 in Q1 2022.
  • Average Interest & Investment Income over 5 years is $7.4 million, with a median of $8.5 million recorded in 2022.
  • The largest annual shift saw Interest & Investment Income surged 1367.52% in 2023 before it tumbled 46.9% in 2025.
  • AbCellera Biologics' Interest & Investment Income stood at $8.5 million in 2022, then increased by 29.5% to $11.0 million in 2023, then dropped by 20.98% to $8.7 million in 2024, then plummeted by 31.7% to $5.9 million in 2025, then plummeted by 38.46% to $3.6 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Interest & Investment Income are $3.6 million (Q1 2026), $5.9 million (Q4 2025), and $6.8 million (Q3 2025).